Column GROUP L P, Director, 10% Owner at NGM BIOPHARMACEUTICALS INC (NGM), bought 278,296 shares at $4.99 ($1.4M) on 2022-11-03, disclosed to the SEC on 2022-11-07.
Open-market purchase of $1.4M NGM by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.99 | 104,090 | $519K | 37.9% |
| 2 | $4.99 | 104,090 | $519K | 37.9% |
| 3 | $4.72 | 35,058 | $165K | 12.1% |
| 4 | $4.72 | 35,058 | $165K | 12.1% |
| Total | $4.92 avg | 278,296 | $1.4M | 100% |
| Filing → |
| NGM | BUY | 2023-01-12 | $2.0M | — | Filing → |
| NGM | BUY | 2022-10-31 | $747K | — | Filing → |
| NGM | BUY | 2022-05-23 | $779K | — | Filing → |